Cabenuva Ad (ViiV Healthcare)

Glax­o­SmithK­line’s Vi­iV Health­care aims to shift HIV dai­ly pill think­ing in first DTC ads

For as long as there have been HIV med­i­cines, the on­ly op­tions for pa­tients have been dai­ly pills — un­til this year that is. Glax­o­SmithK­line’s Vi­iV …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.